Diagnósticos da América S.A.

São Paulo Stock Exchange DASA3.SA

Diagnósticos da América S.A. Receivables for the year ending December 31, 2023: USD 1.01 B

Diagnósticos da América S.A. Receivables is USD 1.01 B for the year ending December 31, 2023, a 30.44% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

Diagnósticos da América S.A. Receivables for the year ending December 31, 2022 was USD 771.37 M, a 86.82% change year over year.
Diagnósticos da América S.A. Receivables for the year ending December 31, 2021 was USD 412.88 M, a -6.31% change year over year.
Diagnósticos da América S.A. Receivables for the year ending December 31, 2020 was USD 440.70 M, a 80.27% change year over year.
Diagnósticos da América S.A. Receivables for the year ending December 31, 2019 was USD 244.47 M, a 21.81% change year over year.

Key data

Date	Receivables	Inventory	Goodwill	Total Assets

São Paulo Stock Exchange: DASA3.SA

Diagnósticos da América S.A.

CEO	Mr. Licio Tavares Angelo Cintra
IPO Date	Nov. 19, 2004
Location	Brazil
Headquarters	Av. JuruA, 434
Employees	18,142
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Clinical Trials Dental Care Drugstores & Retail Pharmacies Medical Instruments Telehealth

Description

Diagnósticos da América S.A. provides diagnostic test services in Latin America. It offers approximately 3,000 types of examinations of clinical analyses and diagnostic imaging services. The company also provides support services to approximately 5,000 laboratories under the Alvaro brand, as well as operates for the public sector under the CientíficaLab brand. The company was formerly known as Laboratório Clínico Delboni Auriemo S.A. and changed its name to Diagnósticos da América S.A. in August 17, 2000. The company was founded in 1966 and is based in Barueri, Brazil.

Key trends

Past 5 years